At the end of 90 days , the coronary flow reserve was improved in the three groups ( fluvastatin-treated group : 23.2 % ; diltiazem-treated group : 12.4 % ; fluvastatin + diltiazem-treated group : 29.1 % , all P < 0.05 ) .